Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Immunotherapy HNSCC

Robert Ferris

MD, PhD

🏢University of Pittsburgh Medical Center🌐USA

Director, UPMC Hillman Cancer Center

75
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Robert Ferris directs the UPMC Hillman Cancer Center and is a world leader in immunotherapy for head and neck squamous cell carcinoma. He has contributed to pivotal trials including KEYNOTE-048 (pembrolizumab first-line HNSCC) and CheckMate 141 (nivolumab recurrent HNSCC). His laboratory work has characterized the tumor immune microenvironment in HPV+ and HPV- HNSCC and identified biomarkers predicting immunotherapy response. He is recognized for bridging immunological discovery with landmark clinical trial results in HNSCC.

Share:

🧪Research Fields 研究领域

pembrolizumab HNSCC
nivolumab HNSCC
KEYNOTE-048
CheckMate 141
tumor immune microenvironment HNSCC

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Robert Ferris 的研究动态

Follow Robert Ferris's research updates

留下邮箱,当我们发布与 Robert Ferris(University of Pittsburgh Medical Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment